Learn from GovCon Expert Chuck Brooks about how and why we can protect critical infrastructure amidst the proliferation of AI ...

Q1 2025 Earnings Call Transcript May 12, 2025 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0 ...

It is definitely time for some analysis and deep reflection by the New Democratic Party. The loss of many of its federal seats can be blamed on the vote split and how unfair it was for Liberals, after ...

Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ETCompany ParticipantsLouisa Smith - The Gilmartin GroupAntony Koblish ...

In a peer-reviewed study authored by Sunil Yadav, a research scholar with a strong academic background in information systems, the author emphasizes how foundational database design strategies shape ...

Operator: Good day, and thank you for standing by. Welcome to AVITA Medical First Quarter 2025 Earnings Conference Call. At ...

Axogen, Inc. ( NASDAQ: AXGN) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Michael Dale - Chairman & Chief Executive Officer Nir Naor - Chief Financial Officer Jens Kemp - Chief Marketing ...

Advancing commercial readiness efforts with a planned Q1 2026 launch of Anaphylm, subject to FDA approval "In the first quarter of 2025, we achieved a major milestone for Aquestive with the submission ...

Monthly issue of the UNRIC Info Point & Library Newsletter featuring new UN websites, publications and information products. Topic of the month: UN80 ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

Submitted NDA for Anaphylm (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a planned Q1 2026 launch of An ...

We tested 20 solar generators to find the most versatile devices that can provide emergency backup power and fuel off-grid ...